Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: the randomized, double‐blind, phase II/III systemic lupus …

…, DJ Wallace, JC Shanahan, KM Latinis… - … : Official Journal of …, 2010 - Wiley Online Library
Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus
(SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE …

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

W Stohl, F Hiepe, KM Latinis, M Thomas… - Arthritis & …, 2012 - Wiley Online Library
Latinis has received consulting fees and speaking fees from Human Genome Sciences, Inc.
Latinis has received consulting fees and speaking fees from Human Genome Sciences, Inc. …

Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)

JT Merrill, JP Buyon, RA Furie, KM Latinis, C Gordon… - Lupus, 2011 - journals.sagepub.com
The EXPLORER study was designed to assess the response to rituximab versus placebo in
patients with moderate to severe extrarenal systemic lupus erythematosus (SLE) receiving …

[HTML][HTML] Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells

KM Latinis, LA Norian, SL Eliason… - Journal of Biological …, 1997 - ASBMB
Antigen receptor engagement on T lymphocytes activates transcription factors important for
stimulating cytokine gene expression. This is critical for clonal expansion of antigen-specific …

Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter

M Faris, KM Latinis, SJ Kempiak… - Molecular and cellular …, 1998 - Am Soc Microbiol
T lymphocytes undergo apoptosis in response to a variety of stimuli, including exposure to
UV radiation and γ-irradiation. While the mechanism by which stress stimuli induce apoptosis …

Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 …

WW Chatham, DJ Wallace, W Stohl, KM Latinis… - The Journal of …, 2012 - jrheum.org
LATINIS, SUSAN MANZI, W. JOSEPH McCUNE, DANA TEGZOVÁ, JAMES D. McKAY, …
Wallace and Latinis have received consulting fees, speaking fees, and/or honoraria from HGS …

Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events.

KM Latinis, LL Carr, EJ Peterson, LA Norian… - … (Baltimore, Md.: 1950 …, 1997 - journals.aai.org
Stimulation of mature peripheral T cells by TCR engagement results in activation of signals
that drive induction of cytokine gene expression and clonal expansion. However, under some …

Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells

KM Latinis, GA Koretzky - 1996 - ashpublications.org
Stimulation through the Fas/APO-1 receptor results in apoptosis through an incompletely
characterized signaling pathway. More is known regarding signal transduction events that …

Signaling events in T lymphocytes leading to cellular activation or programmed cell death

MA Musci, KM Latinis, GA Koretzky - Clinical immunology and …, 1997 - Elsevier
INTRODUCTION PTK (6–9). Interestingly, however, unlike growth factor receptors (such as
the epidermal growth factor re-StimulationofTlymphocytesviatheirantigenrecep-ceptor or …

14. Immunologic rheumatic disorders

…, LE Kahl, P Ranganathan, KM Latinis… - Journal of allergy and …, 2003 - Elsevier
We provide the basics for the clinician who might be called on to consider the diagnosis of
diseases such as systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) in their …